Security key
432705101
- Security type / class
- Equity / COM
- Total 13F shares
- 88,328
- Total 13F value
- $73,000
- Share change
- -24,274
- SEC-reported price per share
- $0.83
- Number of holders
- 6
- Value change
- -$16,454
- Number of buys
- 5
- Number of sells
- 6
Report period
Q3 2022
Institutions
6
Top holders
6
THAR full security history
Ownership snapshot
Full 13F holder table
Canton Strategic Holdings, Inc. SEC filings
Canton Strategic Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of THAR - HILLSTREAM BIOPHARMA INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Highpoint Pharmaceuticals...
Disclosed value leader
Highpoint Pharmaceuticals...
Comparable rows
0/12
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $489,028
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Highpoint Pharmaceuticals LLC has the largest disclosed position value at $489K.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Highpoint Pharmaceuticals LLC's linked filing trail.
Disclosed position value
Top 5
Highpoint Pharmaceuticals LLC
$489K
Kufe LLC
$407.6K
Surender Kharbanda
$362.8K
Varinder Kaur
$328.5K
Sandeep Laumas
$319.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Highpoint Pharmaceuticals LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$489,028
972,222 shares
|
— | 11 Jan 2022 |
| Kufe LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$407,629
810,395 shares
|
— | 11 Jan 2022 |
| Surender Kharbanda |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$362,784
721,240 shares
|
— | 11 Jan 2022 |
| Varinder Kaur |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$328,489
653,059 shares
|
— | 11 Jan 2022 |
| Sandeep Laumas |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$319,912
636,008 shares
|
— | 11 Jan 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$23,000
29,515 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
88,328
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
7
Q3 2022 holders
6
Holder diff
-1
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|